6ZKW image
Entry Detail
PDB ID:
6ZKW
Keywords:
Title:
Crystal structure of InhA:01 TCR in complex with HLA-E bound to InhA (53-61)
Biological Source:
PDB Version:
Deposition Date:
2020-06-30
Release Date:
2022-01-26
Method Details:
Experimental Method:
Resolution:
2.26 Å
R-Value Free:
0.28
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:HLA class I histocompatibility antigen, alpha chain E
Chain IDs:A
Chain Length:276
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Beta-2-microglobulin
Chain IDs:B
Chain Length:100
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Enoyl-[acyl-carrier-protein] reductase [NADH]
Chain IDs:C
Chain Length:9
Number of Molecules:1
Biological Source:Mycobacterium tuberculosis H37Rv
Polymer Type:polypeptide(L)
Description:T-cell receptor alpha chain
Chain IDs:D
Chain Length:199
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:T-cell receptor beta chain
Chain IDs:E
Chain Length:245
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structure-guided stabilization of pathogen-derived peptide-HLA-E complexes using non-natural amino acids conserves native TCR recognition.
Eur.J.Immunol. 52 618 632 (2022)
PMID: 35108401 DOI: 10.1002/eji.202149745

Abstact

The nonpolymorphic class Ib molecule, HLA-E, primarily presents peptides from HLA class Ia leader peptides, providing an inhibitory signal to NK cells via CD94/NKG2 interactions. Although peptides of pathogenic origin can also be presented by HLA-E to T cells, the molecular basis underpinning their role in antigen surveillance is largely unknown. Here, we solved a co-complex crystal structure of a TCR with an HLA-E presented peptide (pHLA-E) from bacterial (Mycobacterium tuberculosis) origin, and the first TCR-pHLA-E complex with a noncanonically presented peptide from viral (HIV) origin. The structures provided a molecular foundation to develop a novel method to introduce cysteine traps using non-natural amino acid chemistry that stabilized pHLA-E complexes while maintaining native interface contacts between the TCRs and different pHLA-E complexes. These pHLA-E monomers could be used to isolate pHLA-E-specific T cells, with obvious utility for studying pHLA-E restricted T cells, and for the identification of putative therapeutic TCRs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures